Article Information
History
- July 10, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Jatin Narang1,†,
- Samreen Jatana2,†,
- András K. Ponti2,
- Ryan Musich2,
- Joshua Gallop1,
- Angela H. Wei1,
- Sokhna Seck1,
- Jessica Johnson1,
- Lynne Kokoczka3,
- Amy S. Nowacki1,4,
- Jeffrey D. McBride5,
- Eduardo Mireles-Cabodevila3,
- Steven Gordon6,
- Kevin Cooper7,
- Anthony P. Fernandez8,9,* and
- Christine McDonald1,2,10,*
- 1Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, Cleveland, Ohio
- 2Department of Inflammation & Immunity, Lerner Research Institute, Cleveland Clinic, Ohio
- 3Medical Intensive Care Unit, Cleveland Clinic, Cleveland, Ohio
- 4Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, Ohio
- 5Department of Dermatology, The University of Oklahoma College of Medicine, Oklahoma City, Oklahoma
- 6Department of Infectious Disease, Cleveland Clinic, Cleveland, Ohio
- 7Department of Dermatology, University Hospitals Cleveland Medical Center, Cleveland, Ohio
- 8Department of Dermatology, Dermatology & Plastic Surgery Institute, Cleveland Clinic, Cleveland, Ohio
- 9Department of Anatomic Pathology, Pathology & Lab Medicine, Cleveland Clinic, Cleveland, Ohio
- 10Department of Molecular Medicine, Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, Cleveland, Ohio
- ↵*Corresponding authors. Email: mcdonac2{at}ccf.org (C.M.); fernana6{at}ccf.org (A.P.F.)
↵† These authors contributed equally to this work.
Posted July 10, 2022.
Abnormal thrombosis and neutrophil activation increases the risk of hospital-acquired sacral pressure injuries and morbidity in patients with COVID-19
